Crossmark

Multi-window CT based Radiomic signatures in differentiating indolent versus aggressive lung cancers in the National Lung Screening Trial: a retrospective study

Crossref DOI link: https://doi.org/10.1186/s40644-019-0232-6

Published Online: 2019-06-28

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lu, Hong

Mu, Wei

Balagurunathan, Yoganand

Qi, Jin

Abdalah, Mahmoud A.

Garcia, Alberto L.

Ye, Zhaoxiang

Gillies, Robert J.

Schabath, Matthew B.
Funding

Funding for this research was provided by:

National Cancer Institute (U01-CA143062; U01-CA200464; U01-CA 186145; U01- CA196405)

Cancer Center Support Grant at the H. Lee Moffitt Cancer Center and Research Institute (CCSG)

NCI designated Comprehensive Cancer Center (P30-CA76292)
License Information

Text and Data Mining valid from 2019-06-28

Version of Record valid from 2019-06-28
More Information

Article History

Received: 15 April 2019

Accepted: 19 June 2019

First Online: 28 June 2019

Ethics approval and consent to participate

: This retrospective study was approved by the Institutional Review Board (IRB) at University of South Florida (USF) and informed consent was waived.

: Not applicable.

: Dr.Gillies is a member of the Advisory Board of HealthMyne, Inc. The remaining authors have stated that they have no conflicts of interest.

Document is current

Any future updates will be listed below